Dennis R. Gable, MD, RVT, FACS

Texas Vascular Associates, PA
4716 Alliance Blvd.
Suite 200
Plano, Texas 75093
Phone: (972) 665-9100
FAX: (972) 665-4711

Dr. Gable sees patients at our Plano, Richardson and Renner clinic locations.

Click Here To See Dr. Gable’s HealthGrades.com Rating

Education

  • Fellowship – Baylor University Medical Center Dallas, Texas. Peripheral Vascular Surgery. July 1997- June 1998
  • General Surgery Chief Resident – University of Louisville, Kentucky. 1996 – 1997
  • General Surgery Residency – University of Louisville, Kentucky. 1993 – 1996
  • General Surgery Internship – University of Louisville, Kentucky. 1992 -1993
  • Medical School – Baylor College of Medicine, Houston, Texas. 1992
  • BA Degree – Chemistry – Baylor University, Waco, Texas. 1988

Certifications

  • Certification American Board of Surgery – Vascular Surgery. 2007
  • Certification American Board of Surgery – General Surgery. 2006
  • Registered Vascular Technologist. 2000
  • Certification American Board of Surgery – Vascular Surgery. 1999
  • Certification American Board of Surgery – General Surgery. 1998
  • Advanced Cardiac Life Support Provider
  • Basic Life Support Provider

Professional Associations

  • Society for Vascular Surgery—Distinguished Fellow
    • Community Practice Committee 2008- 2012
      • Chairman 2010-2012
    • Membership Committee 2012- Present
      • Chairman 2014-Present
    • Public and Professional Outreach Committee 2013-2014
  • Society for Vascular Surgery–Vascular Quality Initiative
    • Quality Committee Regional Representative 2013-Present
      • Regional Director – 2014
    • Arterial Quality Committee 2013-Present
  • Fellow-American College of Surgeons
  • Southern Association for Vascular Surgery
  • Peripheral Vascular Surgical Society
  • Society for Clinical Vascular Surgery
  • Society of Vascular Technology
  • Texas Medical Association
  • North Texas Chapter- American College of Surgeons
  • Dallas County Medical Society
  • Jesse E. Thompson Medical Society
  • Hiram C. Polk Jr, Surgical Society

Academic Appointments

  • Attending Surgeon Department of General and Vascular Surgery – Baylor University Medical Center, Dallas, Texas
  • Volunteer Faculty – University of Texas Southwestern Medical School. 2001 – present
  • Director of Medical Student Education in Vascular Surgery at Baylor University Medical Center for University of Texas Southwestern Medical School

Hospital Appointments

  • Baylor University Medical Center, Dallas, Texas – Active and Teaching Staff
    • Fellowship Clinical Competency Committee 2014
    • Member-Percutaneous Transluminal Angioplasty Committee, 2000-2009
    • Member – Geriatric Medicine Committee – 2000 – 2003
  • Baylor Hamilton Heart Hospital, Dallas, Texas-  Active and Teaching Staff
    • Medical Leadership Committee 2006-2008
    • Medical Director Non-Invasive Vascular Lab 2006-2008
    • Board of Directors 2003-2005
  • Baylor Regional Medical Center at Plano, Plano, Texas
    • President 2010-2012
    • Vice Chairman-Surgery 2005-Present
    • Chief of Vascular Surgery 2005- Present
    • Medical Executive Committee 2005-Present
    • Credentials Committee 2004-2010
      • Chairman 2007-2008
    • Peer Review Committee 2005-Present
      • Chairman 2013-Present
  • Baylor Plano Heart Hospital -Plano, Texas
    • Board of Directors 2010-Present
    • Director Vascular Center of Excellence 2006-Present
    • Chief of Vascular Surgery 2006-Present
    • Medical Leadership Board, 2006-Present
  • Baylor Quality Alliance
    • Board of Directors 2012- Present
  • Richardson Regional Medical Center, Richardson, Texas-Active Staff
    • Credentials Committee Member 2007
    • Chairman-Surgery 2006
    • Medical Executive Committee Member 2006
    • Vice Chairman-Surgery 2005
    • Peer Review Committee 2005
    • Patient Care Committee 2004

Bibliography – Publications/Chapters

  1. Kane K, Fisher T, Bennett M, Shutze Jr. W, Hicks T, Grimsley BGable DPearl GSmith B, Shutze Sr. W. The Incidence and Outcome of Endothermal Heat-Induced Thrombosis After Endovenous Laser Ablation. Ann Vasc Surg. 2014:28, 1744-50.
  2. Saxon RR, Chervu A, Jones PA, Bajwa TK, Gable DR, Soukas PA, et al. Heparin bonded, expanded polytetrafluoroethylene lined stent graft in the treatment of femoral popliteal artery disease: 1-year results of the VIPER (Viabahn Endoprosthesis with Heparin Bioactive Surface in the Treatment of Superficial Femoral Artery Obstructive Disease) trial. JVIR 2013:24(12):165-73.
  3. Satiani B, Mathews M, Gable D. Work Effort, Productivity, and Compensation Trends in Members of the Society for Vascular Surgery. Vasc and Endovas Surg 2012:46(7):508-13.
  4. Satiani BB, Motew SJ, Darling RC, Jain KM, Wixon CL, Johnson BA, Weiss VJ, Gable DR. Changing Practice Paradigms: Negotiating Your Future. J Vasc Surg 2012;55(4):1206-12.
  5. Gable DR. Role of Total Endoluminal Superficial Femoral Artery Bypass. J Cardiovasc Surg 2011:52(5):683-700.
  6. Gierman J, McQuade K, Shutze WHohmann SPearl GSmith BGable DGrimsley BKedora J, Dunn T. Treatment of Proximal Vertebral Artery Disease. J Vasc Surg 2010;52, No. 6:1746.
  7. McQuade K, Gable DPearl G, Theune B, Black S. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2010;52, No.3:584-91.
  8. Golarz S, Gable D. Use of a Viabahn Stent for Repair of a Common Carotid Artery Pseudoaneurysm and Dissection. Ann Vasc Surg 2010:In Press.
  9. McQuade K, Gable DHohman SPearl G, Theune B. Two-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 2009;49, No.1:109-16.
  10. Apple J, McQuade K, Hamman B, Hebeler R, Shutze WGable D. Initial experience in the treatment of thoracic aortic aneurismal disease with a thoracic aortic endograft at Baylor University Medical Center. BUMC Proceedings 2008, 21, No.2:115-19.
  11. Kedora JHohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of Percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45, No. 1:10-16.
  12. Brown BJ, Zachary S, Rogers L, Ellis-Stoll C, Gable DR, Ramsay MA. Use of dexmedetomidine versus general anesthesia for endovascular repair of abdominal aortic aneurysms. BUMC Proceedings 2006;19, No.3:213-15.
  13. Davidson IJA, Bartsch CC, Brava RNK, Gable D, Munschauer C. Stretch expanded polytetrafluoroethylene graft with intra-wall radial support system: an advance in vascular access graft design. J Vasc Access 2004;5:93-98.
  14. Gable DR, Bergamini T, Garrett WV, Hise J, Smith BLShutze WPPearl GJGrimsley BR. Intermediate follow-up of carotid artery stent placement. Am J Surg 2003;185,No.3:183-87.
  15. Munschauer CE, Gable DR. Vascular access coordination at a large tertiary care hospital. Vascular Access For Hemodialysis-VIII. ArlingtonHeights, Illinois: Precept Medical Press;2002:329-36.
  16. Stratman SL, Kuhn JA, Bell MS, Preskitt JT, O’Brien JC, Gable DR, Stephens JS, McCarty TM. Comparison of quick parathyroid assay for uniglandular and multiglandular parathyroid disease. Am J Surg 2002;184:578-81.
  17. Shutze WPGable DR, Garrett WV, et al. Repair of a mycotic aneurysm of the infrarenal aorta in a patient with HIV, using a Palmaz stent and autologous femoral vein graft. Ann Vasc Surg 2002;16,No.4:521-23.
  18. Patetsios P, Gable DR, Garrett WV, Lamont JP, Kuhn JA, Shutze WP, Kourlis H, Grimsley BR, Pearl GJ, Smith BL, Talkington CM, Thompson JE. The management of carotid paragangliomas and review of a 30 year experience. Ann Vasc Surg 2002;16, No.3:331-38.
  19. Lamont JP, Pearl GJ, Patetsios P, Warner MT, Gable DR, Garrett WV, Grimsley BRSmith BLShutze WP. Prospective evaluationof endoluminal venous stents in the treatment of May-Thurner syndrome. Ann Vasc Surg 2002;16, No.1:61-4.
  20. Grimsley BR, Wells JK, Pearl GJ, Garrett WV, Shutze WP, Talkington M, Gable DRSmith BL, Thompson JE. Bovine pericardial patch angioplasty in carotid endarterectomy. Am Surgeon 2001;67:890-95.
  21. Allen JW, Gable DR, Abou-Jaoude W, Polk, Jr. HC. Mesenteric venous thrombosis: a renewed diagnostic and therapeutic challenge. J KMA 2000;98, No.5:202-9.
  22. Shutze WPPearl GJSmith BLGable DR, et al. Endovascular “repair” of abdominal aortic aneurysm and iliac artery aneurysm. BUMC Proceedings 1999;12:155-57.
  23. Pasic R, Mullins F, Gable DR, Levine RL. Major vascular injuries in laparoscopy. J Gyn Surg 1998;14:123-28.
  24. Carrillo EH, Schmacht DC, Gable DR, Fulton RL, Richardson JD. Thoracoscopy in the management of persistent post-traumatic pneumothorax. J Am Coll Surg 1998;186:636-40.
  25. Gable DR, Allen JW, Harrel DJ, Carrillo EH. Endoscopic treatment of post- traumatic “Bilhemia”: case report. J Trauma 1997;43:541-44.
  26. Gable DR, Allen JW, Richardson JD. Blunt popliteal artery injury: is physical exam alone enough for evaluation? J Trauma 1997;43:534-36.
  27. Gable DR, Bergamini TM, Livingston CK, Richardson JD. Surgical implications of hypercoagulable syndromes. Am Surgeon 1997;63:163-69.
  28. Edwards MJ, Gable DR, Richardson JD. The rationale for esophagectomy as the optimal therapy for Barrett’s esophagus with high grade dysplasia. Ann Surg 1996; 223:585-91.
  29. Mullica DF, Sappenfield EL, Gable DR, Tims TA. Crystal structure analysis if 1:3 (Lu, In)(OH)3 and 1:3 (Yb, In)(OH)3. J Less Comm Metals 1989;152:157-63.
  30. Mullica DF, Sappenfield EL, Gable DR. Synthesis, spectral analysis and x-ray diffraction studies of 1:1 (Sc, In)(OH)3. J Less Comm Metals 1988; 142:341-47.
  31. Mullica DF, Sappenfield EL, Gable DR. Synthesis, spectroscopic studies and crystal structure analysis of 1:1 (Lu, In)(OH)3. Inorganica Chim Acta 1988;143:271-75.

Invited Lectureship

  • Gable, D. Continued Innovation of the GORE Viabahn Endoprosthesis. Society for Vascular Surgery Boston, MA. June 6, 2014.
  • Gable, D. Role of the covered stent-graft and total endoluminal superficial femoral artery bypass. CSVS, Edmonton, Canada. September 14, 2013.
  • Gable, D. Role of the covered stent-graft and total endoluminal superficial femoral artery bypass. JSVS, Nagano, Japan. May 24, 2012.
  • Gable, D. A meta-analysis of abdominal aortic aneurysm repair in the endovascular era: what does the current data tell us about the available endografts? JSVS, Nagano, Japan. May 24, 2012.
  • Gable, D. Endovascular treatment options for lower limb revascularization. Session moderator; Charing Cross Vascular Meeting, London, England, April 17, 2012.
  • Gable D. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. W.L. Gore Asia –Pacific Endovascular Symposium. Hong Kong, China. August 6, 2010.
  • Gable D, McQuade K, Pearl G, Theune B. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. Australian/New Zealand-SVS, Sydney, Australia, October 3, 2009.
  • Gable D, McQuade K, Hohman S, Pearl G, Theune B. Two-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. Charing Cross Vascular Meeting, London, England, April 4, 2009.

Bibliography – Presentations

  1. Gable, D. Clinical Success and Technical Considerations for Covered Stents in the SFA:Key Learning from the VIPER and VIASTAR Studies. LINC, Leipzig, Germany. January 29.2014.
  2. Gable D. How Cost Should Impact Treatment Strategies for Management of SFA Occlusive Disease? Veith Symposium, New York, New York. November 21, 2013.
  3. Gable D. What does the 1-year VIPER data indicate? Gore Symposium. SVS, Washington, DC, June 6, 2012.
  4. Gable, D. Is there a connection between stent graft oversizing and outcomes? What Does the 1-year VIPER data indicate? Charing Cross Vascular Meeting, London, England,April 14, 2012.
  5. Gable D. Management of Peripheral Vascular Disease; Current Options. WL Gore National Launch Symposium. Seoul, South Korea. Oct 12, 2011.
  6. Gable, D. The Role of Covered Stent Grafts in the Superficial Femoral Artery. WL Gore National Launch Meeting, Seoul, South Korea. Oct 8, 2011.
  7. Gable, D. The Role of SFA Endoluminal Bypass in Long De-Novo Lesions. W.L Gore National Sales Meeting, Pheonix, Arizona. May 4, 2011.
  8. Gable D. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. Veith Symposium, New York, New York. November 18, 2010.
  9. Gable D. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. W.L. Gore Asia -Pacific Endovascular Symposium. Hong Kong, China. August 6, 2010.
  10. Gable D, McQuade K, Pearl G, Theune B. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. Southern Assoc for Vasc Surg, Paradise Island, Bahamas. January 21, 2010.
  11. Gable, DR. Group Practice Models: Communist, Socialist, Capitalist, Hospitalist. SVS, Moderator community practice breakfast session. Denver, CO, June 13,2009.
  12. Gable DR. Endovascular treatment of the superficial femoral artery. Presented at the European Society of Vascular Surgery, Nice, France, September 5, 2008.
  13. Kedora JCHohman SE, Dunn TL, Garrett WV, Grimsley BRPearl GJShutze WPSmith BLGable DR. Mid-Term Comparison of Percutaneous Viabahn Stent-Grafts versus Conventional Femoral-Popliteal Bypass in the Treatment of Superficial Femoral Arterial Occlusive Disease. Presented at Society for Vascular Surgery Annual Symposium, Philadelphia, Pennsylvania, June 1-4, 2006.
  14. Kedora JCHohmann SE, Dunn TJ, Garret WV, Grimsley BRPearl GJShutze WPSmith BLGable DR. Comparison of Viabahn Stent Grafts versus Conventional Femoral-Popliteal Bypass in the Treatment of Superficial Femoral Artery Occlusive Disease. Presented at 45th Annual Meeting of the North Texas Chapter of the ACS, Dallas, Texas, Februaury 24-25, 2006.
  15. Gable DR. Lower extremity peripheral arterial occlusive disease. The Baylor Heart and Vascular Cardiovascular Symposium, Dallas, Texas, August 14, 2004.
  16. Davidson IJ, Garrett WV, Smith BLGable DRGrimsley BR, Nichols D, Munschauer CE. Vascular access survival following banding for hand ischemia. Presented at The III International Congress of the Vascular Access Society, Lisbon, Portugal, May 21-23, 2003.
  17. Gable DR, Munschauer CE, Garrett WV, Smith BLPearl GJShutze WPGrimsley BR. Vascular access coordination at a large tertiary care hospital. Presented at Peripheral Vascular Surgery Society 13th Annual Winter Meeting, Snowmass, Colorado, January 31-February 2, 2003.
  18. Gable DR, Munschauer CE. Vascular access coordination at a large tertiary care hospital. Presented at ESRD Network Thirteen Symposium:Vascular Access for Hemodialysis, Dallas, Texas, July 20, 2002.
  19. Gable DR, Munschauer CE. Vascular access coordination at a large tertiary care hospital. Presented at Vascular Access for Hemodialysis Conference, Palm Springs, California, May 10, 2002.
  20. Stroman DL, Smith BL, Goldstein RM, Pearl GJGable DR. Treatment of the septic aorta with in-situ cadaveric homograft. Presented at Society for Clinical Vascular Surgery 30th Annual Symposium on Vascular Surgery, Las Vegas, Nevada March 14, 2002.
  21. Gable DR, Bergamini T, Garrett WV, Hise J, Smith BLShutze WPPearl G, Grimsley BR. Intermediate follow-up of carotid artery stent placement. Presented at 41st Annual Meeting of the North Texas Chapter of the American College of Surgeons, Dallas, Texas, February 22, 2002.
  22. Stratmann SL, Kuhn JA, Bell MS, Gable DR. Comparison of quick parathyroid assay for uniglandular and multiglandular parathyroid disease. Presented at 41st Annual Meeting of the North Texas Chapter of the American College of Surgeons, Dallas, Texas, February 22, 2002.
  23. Gable DR. Reperfusion injury in the vascular patient. Presented at Seminar for Advanced Vascular Nursing, Baylor University Medical Center Dallas, Texas, October 19, 2001.
  24. Patetsios PP, Shutze W, Holden B, Garrett WV, Pearl GJSmith BLGable DRGrimsley BR. Repair of a mycotic aneurysm of the infrarenal aorta with HIV, using a palmaz stent and autologous femoral vein graft. Presented at 15th Annual Eastern Vascular Society Meeting, Washington, D.C., May 3-6, 2001.
  25. Gable DR. Application of endovascular therapy. Presented at Seminar for Advanced Vascular Nursing, Baylor University Medical Center, Dallas, Texas, August 20, 1998.
  26. Carrillo EH, Schmacht DC, Gable DR, Fulton RL, Richardson JD. Thoracoscopy in the management of persistent post-traumatic pneumothorax. Presented at the Paper Session of the 83rd Annual Clinical Congress of the American College of Surgeons, Chicago, Illinois, October 16, 1997.
  27. Gable DR, Bergamini TM, Livingston CK, Richardson JD. Surgical implications of hypercoagulable syndromes. Presented at the 64th Annual Scientific Meeting and Postgraduate Course Program of the Southeastern Surgical Congress, Tampa, Florida February 4-7, 1996.
  28. Edwards MJ, Gable DR, Richardson JD. The rationale for esophagectomy as the optimal therapy for Barrett’s esophagus with high grade dysplasia. Presented at the 107th Annual Session of the Southern Surgical Association, Hot Springs, Virginia December 3-6, 1995.